Skip to main content
Caplight Logo









Optimale

Optimale

Private
LondonHealthcare & Life Scienceshttps://optimale.co.uk/

Last Round

Angel

Sep 11, 2025

Total Funding Raised

$120M

Company Overview

Optimale operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Angel round in September 2025.

Optimale is a healthcare company that provides medical services, diagnostics, and testosterone replacement therapy (TRT) to patients in the United Kingdom.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Subscription Commerce, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Optimale Comparables

Compare Optimale with similar companies based on industry and business-model similarity.

Optimale comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alphagenix Ltd
94%
Balance My Hormones Ltd
94%
Ted's Health
91%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Optimale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelSep 11, 2025
DebtNov 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

David Kennett

COO, Co-Founder

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2025

    Raised an Angel round with participation from James Smith.

Book a demo to see all signals

For institutional investors. Book with your work email.

Optimale Filings

Explore SEC and related filing metadata, where available.

Optimale filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Optimale's valuation, stock price, and market status.

Is Optimale a public or private company?

Optimale is a private company.

What is the current stock price of Optimale?

Optimale is a private company, so its shares have no public market price. Caplight tracks Optimale's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Optimale worth (valuation)?

Valuation information for Optimale is not publicly available.

Can I buy Optimale stock?

Optimale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Optimale's last funding round?

Optimale's most recent funding round was Angel on September 11, 2025.

Who are the main investors in Optimale?

Investor information for Optimale is not publicly disclosed.

Will Optimale IPO soon?

No public IPO plans have been announced for Optimale.

How can I track Optimale secondary market activity?

Caplight tracks bids, offers, and trades in Optimale's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2017
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?